QSAR of d4T nucleoside analogues against HIV-1 activity

被引：0
|
作者：
Li, J. [1 ]
Xie, H. [1 ]
Zhang, J. [1 ]
Cao, W. [1 ]
机构：
[1] Faculty of Science, Beijing Univ. of Chemical Technology, Beijing 100029, China
来源：
Beijing Huagong Daxue Xuebao(Ziran Kexueban)/Journal of Beijing University of Chemical Technology | 2001年 / 28卷 / 01期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In this paper, quantitative structure-activity relationships (QSAR) of 20 compounds which belong to nucleoside analogue were studied by using the method of molecular connectivity index, and one equation of QSAR was established (R = 0.94). The model revealed that the anti-HIV-1 activity was significantly correlated with the nM, lg P, (lg P)2 and 6χPv. As known from the equation, the molecular connectivity index 6χPv played more important role than that of the electronic parameter σ.
引用
收藏
页码：79 / 80
相关论文
共 50 条
  • [41] A QSAR study investigating the effect of L-alanine ester variation on the anti-HIV activity of some phosphoramidate derivatives of d4T
    Knaggs, MH
    McGuigan, C
    Harris, SA
    Heshmati, P
    Cahard, D
    Gilbert, IH
    Balzarini, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (18) : 2075 - 2078
  • [42] Anti-HIV activity of novel phosphonate derivatives of AZT, d4T, and ddA
    Pokrovsky, AG
    Pronayeva, TR
    Fedyuk, NV
    Shirokova, EA
    Khandazhinskaya, AL
    Tarusova, NB
    Karpenko, IL
    Krayevsky, AA
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2001, 20 (4-7): : 767 - 769
  • [43] Polyfluoroaromatic stavudine (d4T) ProTides exhibit enhanced anti-HIV activity
    Kandil, Sahar
    Pannecouque, Christophe
    Chapman, Fiona M.
    Westwell, Andrew D.
    McGuigan, Christopher
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (24)
  • [44] QSAR studies on some anti HIV-1 drugs: Deoxy analogues of HEPT(1)
    Agrawal, V. K.
    Singh, J.
    Karmarkar, S.
    Khadikar, P. V.
    OXIDATION COMMUNICATIONS, 2006, 29 (04): : 793 - 802
  • [45] The Nucleoside Analogue D-carba T Blocks HIV-1 Reverse Transcription
    Boyer, Paul L.
    Vu, B. Christie
    Ambrose, Zandrea
    Julias, John G.
    Warnecke, Svenja
    Liao, Chenzhong
    Meier, Chris
    Marquez, Victor E.
    Hughes, Stephen H.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (17) : 5356 - 5364
  • [46] QSAR and Docking Studies of DATA Analogues as HIV-1 Reverse Transcriptase Inhibitors
    Tong, Jianbo
    Lei, Shan
    Zhan, Pei
    Qin, Shangshang
    Wang, Yang
    LETTERS IN DRUG DESIGN & DISCOVERY, 2019, 16 (02) : 153 - 159
  • [47] QSAR analysis of some phthalimide analogues based inhibitors of HIV-1 integrase
    Bansal, Ruchi
    Karthikeyan, C.
    Moorthy, N. S. Hari Narayana
    Trivedi, Piyush
    ARKIVOC, 2007, : 66 - 81
  • [48] SAFETY AND INTERACTION OF DDL AND D4T IN ASYMPTOMATIC HIV PATIENTS
    SEIFERT, RD
    CUTLER, NR
    SRAMEK, JJ
    STEWART, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 193 - 193
  • [49] Adding Saquinavir to d4T in advanced HIV infected patients
    Rutschmann, OT
    Kaiser, L
    Fathi, M
    Perrin, L
    Hirschel, B
    AIDS, 1996, 10 : P41 - P41
  • [50] A comparative QSAR study on 2-amino-6-arylsulfonylbenzonitrile analogues as non-nucleoside reverse transcriptase inhibitors of HIV-1
    Pancholi, Nilanjana
    Sapre, Nitin S.
    ASIAN JOURNAL OF CHEMISTRY, 2007, 19 (02) : 1251 - 1261
12345